Richard L, Velasco P, Detmar M
Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA.
Methods Mol Med. 1999;18:261-9. doi: 10.1385/0-89603-516-6:261.
The cultivation of endothelial cells from large vessels, predominantly from human umbilical veins (1,2), has become a routine procedure in many laboratories and has contributed to the development of modern vascular biology. However, there is convincing evidence that microvascular endothelial cells display a number of important functional differences, compared to large vessel-derived endothelial cells (3), in particular, with regard to their growth factor response (4,5) and their regulation of adhesion molecule expression (6-8). Since endothelial cells involved in the pathogenesis of tumor angiogenesis, wound healing, and acute and chronic inflammation are predominantly of microvascular origin, techniques have been developed to isolate endothelial cells from small vessels, most frequently from the skin (5,9-13). The culture of human dermal microvascular endothelial cells (HDMEC) has remained problematic because of difficulties in cell isolation, low cell yields, and short lifespans of the isolated cells. In particular, potential contamination of HDMEC cultures with fibroblasts required time-consuming density-gradient centrifugations (5,12) or mechanical removal of fibroblasts (10), and remained problematic after several cell passages. We established a simplified protocol that allows the rapid and reliable immunomagnetic isolation of a well characterized, 100% pure population of HDMEC from neonatal human foreskins. This technique is based on the endothelial cell-specific induction of E-selectin by tumor necrosis factor-alpha (TNF-α) (14), predominantly in postcapillary venule endothelial cells (15), and selection of E-selectin-expressing cells by Dynabeads coupled with an anti-E-selectin monoclonal antibody.
从大血管,主要是从人脐静脉培养内皮细胞(1,2),已在许多实验室成为常规操作,并推动了现代血管生物学的发展。然而,有令人信服的证据表明,与大血管来源的内皮细胞相比,微血管内皮细胞呈现出许多重要的功能差异(3),特别是在其生长因子反应方面(4,5)以及对黏附分子表达的调节方面(6 - 8)。由于参与肿瘤血管生成、伤口愈合以及急慢性炎症发病机制的内皮细胞主要源自微血管,因此已开发出从微小血管,最常见的是从皮肤分离内皮细胞的技术(5,9 - 13)。人真皮微血管内皮细胞(HDMEC)的培养一直存在问题,因为细胞分离困难、细胞产量低以及分离出的细胞寿命短。特别是,HDMEC培养物中潜在的成纤维细胞污染需要耗时的密度梯度离心(5,12)或机械去除成纤维细胞(10),并且在多次细胞传代后仍然存在问题。我们建立了一种简化方案,可从新生儿包皮中快速可靠地免疫磁珠分离出特征明确、100% 纯的HDMEC群体。该技术基于肿瘤坏死因子 -α(TNF-α)对E - 选择素的内皮细胞特异性诱导(14),主要发生在毛细血管后微静脉内皮细胞中(15),并通过与抗E - 选择素单克隆抗体偶联的磁珠选择表达E - 选择素的细胞。